Primary immunodeficiency diseases worldwide: More common than generally thought

Journal of Clinical Immunology

Volumn 33, Issue 1, 2013, Pages 1-7

  Bousfiha, Ahmed Aziz ^a   Jeddane, Leila ^a,b   Ailal, Fatima ^a   Benhsaien, Ibtihal ^a   Mahlaoui, Nizar ^c   Casanova, Jean Laurent ^c,d,e   Abel, Laurent ^d,e  

^a CHU Averroes   (Morocco)

^b MOHAMMED V UNIVERSITY   (Morocco)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d ROCKEFELLER UNIVERSITY   (United States)

^e IMAGINE INSTITUTE   (France)

Author keywords

Incidence; Mortality; Prevalence; Primary immunodeficiency

Indexed keywords

ARTICLE; ASIA; AUSTRALIA; EPIDEMIOLOGICAL DATA; EUROPE; FRANCE; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; IRAN; JAPAN; MOROCCO; NEW ZEALAND; NORTH AMERICA; PACIFIC ISLANDS; PREVALENCE; PRIORITY JOURNAL; RARE DISEASE; REGISTER; SOUTH AMERICA; TELEPHONE INTERVIEW; ADOLESCENT; CHILD; CHRONIC GRANULOMATOUS DISEASE; COMMON VARIABLE IMMUNODEFICIENCY; IMMUNOLOGY; INFANT; PRESCHOOL CHILD; QUALITY OF LIFE; QUESTIONNAIRE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COMMON VARIABLE IMMUNODEFICIENCY; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; INFANT; QUALITY OF LIFE; QUESTIONNAIRES;

MLCS; MLOWN;

EID: 84876442493     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-012-9751-7     Document Type: Article

References (43)

1. Al-Herz W, Bousfiha A, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency. Front Immunol. 2011;2:54. doi:10.3389/fimmu.2011.00054.
2. Notarangelo LD. Primary immunodeficiencies. J Allergy Clin Immunol. 2010;125:S182-94.
3. Casanova JL, Abel L. Primary immunodeficiencies: a field in its infancy. Science. 2007;317:617-9.
4. Notarangelo LD, Casanova JL. Primary immunodeficiencies: increasing market share. Curr Opin Immunol. 2009;21:461-5.
5. Alcais A, Quintana-Murci L, Thaler DS, Schurr E, Abel L, Casanova JL. Life-threatening infectious diseases of childhood: single-gene inborn errors of immunity? Ann NYAcad Sci. 2010;1214:18-33.
6. Casanova JL, Abel L. Inborn errors of immunity to infection: the rule rather than the exception. J Exp Med. 2005;202(2):197-201.
7. Bousfiha A, Picard C, Boisson-Dupuis S, Zhang SY, Bustamente J, Puel A, et al. Primary immunodeficiencies of protective immunity to primary infections. Clin Immunol. 2010;135:204-9.
8. Bassiri H, Janice Yeo WC, Rothman J, Koretzky GA, Nichols KE. X-linked lymphoproliferative disease (XLP): a model of impaired anti-viral, anti-tumor and humoral immune responses. Immunol Res. 2008;42:145-59.
9. Mathew S, Overturf GD. Complement and properidin deficiencies in meningococcal disease. Pediatr Infect Dis J. 2006;25:255-6.
10. Orth G. Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses. Semin Immunol. 2006;18:362-74.
11. Picard C, Puel A, Bonnet M, Ku CL, Bustamante J, Yang K, et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science. 2003;299:2076-9.
12. Altare F, Durandy A, Lammas D, Emile JF, Lamhamedi S, Le Deist F, Drysdale P, et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science. 1998;280:1432-5.
13. de Beaucoudrey L, Samarina A, Bustamante J, Cobat A, Boisson-Dupuis S, Feinberg J, et al. Revisiting IL-12Rb1 deficiency: an international survey of 141 patients from 30 countries. Medicine (Baltimore). 2010;89(6):381-402.
14. Casrouge A, Zhang SY, Eidenschenk C, Jouanguy E, Puel A, Yang K, et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science. 2006;314:308-12.
15. Puel A, Cypowyj S, Bustamante J, Wright JF, Liu L, Lim HK, et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science. 2011;332:65-8.
16. Boisson-Dupuis S, ElBaghdadi J, Parvaneh N, Bousfiha A, Bustamante J, Feinberg J, et al. IL-12Rβ1 deficiency in two of fifty children with severe tuberculosis from Iran, Morocco, and Turkey. PLoS One. 6(4): e18524.
17. Tabarsi P, Marjani M, Mansouri N, Farnia P, Boisson-Dupuis S, Bustamante J, et al. Lethal tuberculosis in a previously healthy adult with IL-12 receptor deficiency. J Clin Immunol. 2011;31 (4):537-9.
18. Rare diseases. In: Health-EU: The Public Health Portal of European Union. 2011. http://ec.europa.eu/health-eu/health-problems/rare-diseases/index-en.htm. Accessed 11 Sept 2011.
19. ESID database statistics. In: European Society for Immunodeficiencies. 2011. http://www.esid.org/statistics.php. Accessed 26 Jan 2012.
20. Kirkpatrick P, Riminton S. Primary immunodeficiency diseases in Australia and New Zealand. J Clin Immunol. 2007;27:517-24.
21. Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol. 2007;27:497-502.
22. Joshi AY, Iyer VN, Hagan JB, Sauver JLS, Boyce TG. Incidence and temporal trends of primary immunodeficiency: a populationbased cohort study. Mayo Clin Proc. 2009;84(1):16-22.
23. CEREDIH: The French PID study group. The French national registry of primary immunodeficiency diseases. Clin Immunol. 2010;135:264-72.
24. Leiva LE, Zelazco M, Oleastro M, Carneiro-Sampaio M, Condino-Neto A, Tavares Costa-Carvalho B, et al. Primary immunodeficiency diseases in Latin America: the second report of the LAGID Registry. J Clin Immunol. 2007;27(1):101-8.
25. Rezaei N, Aghamohammadi A, Moin M, Pourpak Z, Movahedi M, Gharagozlou M, et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry. J Clin Immunol. 2006;26(6):519-32.
26. Barbouche MR, Galal N, Ben Mustapha I, Jeddane L, Mellouli F, Ailal F, et al. Primary immunodeficiencies in highly consanguineous North African populations. Ann N YAcad Sci. 2011;1238:42-52.
27. Total number of patients in the USIDnet registry. In: US Immunodeficiency Network. 2004. http://www.usidnet.org/index.cfm. Accessed 6 Feb 2012.
28. African Society for Immunodeficiencies ASID. 2009. http://www.asid.ma. Accessed 11 Sept 2011.
29. Ishimura M, Takada H, Doi T, Imai K, Sasahara Y, Kanegane H, et al. Nationwide survey of patients with primary immunodeficiency diseases in Japan. J Clin Immunol. 2011;31:968-76.
30. Modell V, Gee B, Lewis DB, Orange JS, Roifman CM, Routes JM, et al. Global study of primary immunodeficiency diseases (PI) diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation. Immunol Res. 2011;51:61-70.
31. World Population Prospects: The 2010 Revision. In: United Nations, Department of Economic and Social Affairs, Population Division. 2011. http://esa.un.org/unpd/wpp/Excel-Data/population.htm. Accessed 23 May 2011.
32. SEER Stat Fact Sheets: Leukemia. In: Surveillance, Epidemiology, and End Results Program. 2010. http://seer.cancer.gov/statfacts/html/leuks.html. Accessed 1 Aug 2011.
33. Tadmouri GO, Nair P, Obeid T, Al Ali MT, Al Khaja N, Hamamy HA. Consanguinity and reproductive health among Arabs. Reprod Health. 2009. doi:10.1186/1742-4755-6-17.
34. Naamane H, El Maataoui O, Ailal F, Barakat A, Bennani S, Najib J, et al. The 752delG26 mutation in the RFXANK gene associated with major histocompatibility complex class II deficiency: evidence for a founder effect in the Moroccan population. Eur J Pediatr. 2010;169(9):1069-74.
35. Picard C, Fieschi C, Altare F, Al-Jumaah S, Al-Hajjar S, Feinberg J, et al. Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds. Am J Hum Genet. 2002;70(2):336-48.
36. Ben Mustapha I, Kammoun A, Mellouli F, Abdelmoula MS, Chemli J, Largueche B, et al. A strong founder effect for a 10-bp deletion in the CD18 gene in North African leukocyte adhesion deficiency type I patients. Clin Exp Immunol. 2008;154:105.
37. Sanchez JJ, Monaghan G, Børsting C, Norbury G, Morling N, Gaspar HB. Carrier frequency of a nonsense mutation in the adenosine deaminase (ADA) gene implies a high incidence of ADA-deficient severe combined immunodeficiency (SCID) in Somalia and a single, common haplotype indicates common ancestry. Ann Hum Genet. 2006;71:336-47.
38. Lisowska-Grospierre B, Fondaneche MC, Rols MP, Griscelli C, Fischer A. Two complementation groups accent for most cases of inherited MHC class II deficiency. Hum Mol Genet. 1994;3:953-8.
39. Ehlayel M, de Beaucoudrey L, Fike F, Nahas SA, Feinberg J, Casanova JL, Gatti RA. Simultaneous presentation of 2 rare hereditary immunodeficiencies: IL-12 receptor beta1 deficiency and ataxia-telangiectasia. J Allergy Clin Immunol. 2008;122(6):1217-9.
40. Lindegren ML, Kobrynski L, Rasmussen SA, Moore CA, Grosse SD, Vanderford ML, et al. Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders. MMWR Recomm Rep. 2004;53:1-29.
41. Subbarayan A, Colarusso G, Hughes SM, Gennery AR, Slatter M, Cant AJ, et al. Clinical features that identify children with primary immunodeficiency diseases. Pediatr. 2011;127(5):810-6.
42. Arkwright PD, Gennery AR. Ten warning signs of primary immunodeficiency: a new paradigm is needed for the 21st century. Ann NY Acad Sci. 2011;1238:7-14.
43. Alcais A, Fieschi C, Abel L, Casanova JL. Tuberculosis in children and adults: two distinct genetic diseases. J Exp Med. 2005;202:1617-21.